225 related articles for article (PubMed ID: 12044976)
1. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system.
Sørensen TL; Trebst C; Kivisäkk P; Klaege KL; Majmudar A; Ravid R; Lassmann H; Olsen DB; Strieter RM; Ransohoff RM; Sellebjerg F
J Neuroimmunol; 2002 Jun; 127(1-2):59-68. PubMed ID: 12044976
[TBL] [Abstract][Full Text] [Related]
2. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions.
Simpson JE; Newcombe J; Cuzner ML; Woodroofe MN
Neuropathol Appl Neurobiol; 2000 Apr; 26(2):133-42. PubMed ID: 10840276
[TBL] [Abstract][Full Text] [Related]
3. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM
J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101
[TBL] [Abstract][Full Text] [Related]
4. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.
Balashov KE; Rottman JB; Weiner HL; Hancock WW
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6873-8. PubMed ID: 10359806
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
Teleshova N; Pashenkov M; Huang YM; Söderström M; Kivisäkk P; Kostulas V; Haglund M; Link H
J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306
[TBL] [Abstract][Full Text] [Related]
6. T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking.
Kivisäkk P; Trebst C; Liu Z; Tucky BH; Sørensen TL; Rudick RA; Mack M; Ransohoff RM
Clin Exp Immunol; 2002 Sep; 129(3):510-8. PubMed ID: 12197893
[TBL] [Abstract][Full Text] [Related]
7. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis.
Eikelenboom MJ; Killestein J; Izeboud T; Kalkers NF; van Lier RA; Barkhof F; Uitdehaag BM; Polman CH
J Neuroimmunol; 2002 Dec; 133(1-2):225-32. PubMed ID: 12446027
[TBL] [Abstract][Full Text] [Related]
9. Optic neuritis: chemokine receptor CXCR3 and its ligands.
Sørensen TL; Roed H; Sellebjerg F
Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
[TBL] [Abstract][Full Text] [Related]
10. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system.
Christensen JE; de Lemos C; Moos T; Christensen JP; Thomsen AR
J Immunol; 2006 Apr; 176(7):4235-43. PubMed ID: 16547260
[TBL] [Abstract][Full Text] [Related]
11. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.
Stiles LN; Hosking MP; Edwards RA; Strieter RM; Lane TE
Eur J Immunol; 2006 Mar; 36(3):613-22. PubMed ID: 16479546
[TBL] [Abstract][Full Text] [Related]
12. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus.
Hsieh MF; Lai SL; Chen JP; Sung JM; Lin YL; Wu-Hsieh BA; Gerard C; Luster A; Liao F
J Immunol; 2006 Aug; 177(3):1855-63. PubMed ID: 16849497
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
Liu MT; Keirstead HS; Lane TE
J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
[TBL] [Abstract][Full Text] [Related]
14. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.
Giunti D; Borsellino G; Benelli R; Marchese M; Capello E; Valle MT; Pedemonte E; Noonan D; Albini A; Bernardi G; Mancardi GL; Battistini L; Uccelli A
J Leukoc Biol; 2003 May; 73(5):584-90. PubMed ID: 12714572
[TBL] [Abstract][Full Text] [Related]
16. Targeting the chemokine receptor CXCR3 and its ligand CXCL10 in the central nervous system: potential therapy for inflammatory demyelinating disease?
Sorensen TL
Curr Neurovasc Res; 2004 Apr; 1(2):183-90. PubMed ID: 16185193
[TBL] [Abstract][Full Text] [Related]
17. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.
Saetta M; Mariani M; Panina-Bordignon P; Turato G; Buonsanti C; Baraldo S; Bellettato CM; Papi A; Corbetta L; Zuin R; Sinigaglia F; Fabbri LM
Am J Respir Crit Care Med; 2002 May; 165(10):1404-9. PubMed ID: 12016104
[TBL] [Abstract][Full Text] [Related]
19. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
